作者:Dominique Amans、Véronique Bellosta、Catherine Dacquet、Alain Ktorza、Nathalie Hennuyer、Bart Staels、Daniel-Henri Caignard、Janine Cossy
DOI:10.1039/c2ob25593f
日期:——
In order to identify new leads for the treatment of type 2 diabetes, polyenic molecules A and B derived from nipecotic acid and dienol derivatives C have been prepared and their effect on PPARs transcriptional activity evaluated and compared to that of rosiglitazone, WY14,643 and GW501516. Among the synthesized compounds, dienol 39 is the most active, increasing WY14,643 PPARα response and demonstrating partial agonist properties on rosiglitazone PPARγ.
为了找到治疗 2 型糖尿病的新线索,我们制备了由尼泊金酸衍生的多烯分子 A 和 B 以及二烯醇衍生物 C,评估了它们对 PPARs 转录活性的影响,并与罗格列酮、WY14,643 和 GW501516 进行了比较。在合成的化合物中,二烯醇 39 的活性最高,它能提高 WY14,643 PPARα 的反应,并显示出对罗格列酮 PPARγ 的部分激动特性。